B-Cells Are Required for the Initiation of Insulitis and Sialitis in Nonobese Diabetic Mice
暂无分享,去创建一个
A. Naji | H. Noorchashm | S. Rostami | N. Noorchashm | Joshua H. Kern | Clyde Barker | Clyde F Barker | Clyde F. Barker
[1] A. B. Lyons,et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help , 1996, The Journal of experimental medicine.
[2] D. Ernst,et al. CD4+ T cell activation and tolerance induction in B cell knockout mice , 1996, The Journal of experimental medicine.
[3] E. Unanue,et al. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.
[4] J. West,et al. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. , 1995, Journal of immunology.
[5] A. Sher,et al. Successful T Cell Priming in B Cell-deficient Mice , 1995 .
[6] A. Lanzavecchia. How can cryptic epitopes trigger autoimmunity? , 1995, The Journal of experimental medicine.
[7] E. Leiter,et al. Genetic and pathogenic basis of autoimmune diabetes in NOD mice. , 1994, Current opinion in immunology.
[8] R. Schwartz,et al. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation , 1994, The Journal of experimental medicine.
[9] J. Rothbard,et al. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. , 1994, Journal of autoimmunity.
[10] M. Jenkins. The ups and downs of T cell costimulation. , 1994, Immunity.
[11] B. Ekstrand-Hammarström,et al. Neonatal treatment with monoclonal natural antibodies restores a normal pattern of VH gene utilization in the non-obese diabetic mouse. , 1994, International immunology.
[12] C. Janeway,et al. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.
[13] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[14] R. Tisch,et al. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.
[15] A. Tobin,et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes , 1993, Nature.
[16] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[17] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[18] E. Leiter,et al. Intrathymic Islet Cell Transplantation Reduces β-Cell Autoimmunity and Prevents Diabetes in NOD/Lt Mice , 1992, Diabetes.
[19] H. Kikutani,et al. The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.
[20] D. Holmberg,et al. Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. , 1991, Journal of autoimmunity.
[21] A. Cooke,et al. The development of insulin-dependent diabetes mellitus in non-obese diabetic mice: the role of CD4+ and CD8+ T cells. , 1991, Biochemical Society transactions.
[22] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[23] A. Cooke,et al. The involvement of Ly2+ T cells in beta cell destruction. , 1990, Journal of autoimmunity.
[24] J. Bach,et al. The nonobese diabetic mouse model. Independent expression of humoral and cell-mediated autoimmune features. , 1990, Journal of immunology.
[25] C. Boitard,et al. Insulin autoantibodies in non-obese diabetic (NOD) mice. , 1989, Clinical and experimental immunology.
[26] G. Eisenbarth,et al. Radioassay Determination of Insulin Autoantibodies in NOD Mice: Correlation With Increased Risk of Progression to Overt Diabetes , 1989, Diabetes.
[27] R. Schwartz,et al. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.
[28] P. Bedossa,et al. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. , 1988, Journal of immunology.
[29] B. Charlton,et al. Administration of Silica Particles or Anti-Lyt2 Antibody Prevents β-Cell Destruction in NOD Mice Given Cyclophosphamide , 1988, Diabetes.
[30] B. Benacerraf,et al. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. , 1988, Journal of immunology.
[31] E. Leiter,et al. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. , 1988, Journal of immunology.
[32] C. Fathman,et al. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. , 1988, Science.
[33] O. Pontesilli,et al. Circulating lymphocyte populations and autoantibodies in non-obese diabetic (NOD) mice: a longitudinal study. , 1987, Clinical and experimental immunology.
[34] J. Sprent,et al. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. , 1987, Journal of immunology.
[35] K. Takabayashi,et al. Preventive Effect of Monoclonal Anti-L3T4 Antibody on Development of Diabetes in NOD Mice , 1987, Diabetes.
[36] C. Janeway,et al. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. , 1987, Journal of immunology.
[37] M. Harada,et al. Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody. , 1986, Jikken dobutsu. Experimental animals.
[38] B. Benacerraf,et al. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. , 1986, Journal of immunology.
[39] P. De Baetselier,et al. Defective induction of antigen‐reactive proliferating T cells in B cell‐deprived mice , 1981, European journal of immunology.